Mediolanum International Funds Ltd lowered its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 16.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 235,959 shares of the company’s stock after selling 46,221 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Procter & Gamble were worth $40,883,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PG. Steele Capital Management Inc. bought a new position in shares of Procter & Gamble in the 1st quarter worth $204,000. GAMMA Investing LLC grew its position in shares of Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares during the period. Consilio Wealth Advisors LLC increased its stake in shares of Procter & Gamble by 27.7% in the 1st quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock valued at $283,000 after acquiring an additional 379 shares during the last quarter. AMF Tjanstepension AB raised its position in shares of Procter & Gamble by 416.1% in the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after acquiring an additional 1,466,115 shares during the period. Finally, Talbot Financial LLC boosted its stake in Procter & Gamble by 1.5% during the 1st quarter. Talbot Financial LLC now owns 65,600 shares of the company’s stock worth $10,644,000 after acquiring an additional 950 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
Shares of NYSE PG opened at $168.22 on Friday. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $177.94. The company has a market cap of $396.16 billion, a PE ratio of 29.00, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The business’s 50 day moving average price is $171.93 and its two-hundred day moving average price is $167.55. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.39%. Procter & Gamble’s dividend payout ratio is 69.48%.
Insider Buying and Selling at Procter & Gamble
In other news, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 397,986 shares of company stock worth $67,642,430 over the last 90 days. Insiders own 0.18% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the stock. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $177.00.
Check Out Our Latest Stock Report on Procter & Gamble
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Industrial Products Stocks Investing
- Texas Roadhouse Stock Steering for New Highs This Year
- How to Effectively Use the MarketBeat Ratings Screener
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Basic Materials Stocks Investing
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.